Research Article| Volume 18, SUPPLEMENT 2, 93-95, 1996

Intravenous immunoglobulin and hepatitis C virus: the British episode

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia
        Intravenous immunoglobulin for the prevention of infection of chronic lymphocytic leukemia.
        NEJM. 1988; 319: 902-907
        • Chapel HM
        Consensus on diagnosis and management of primary antibody deficiencies.
        BMJ. 1994; 308: 581-585
        • Lever AM
        • Webster AD
        • Brown D
        • Thomas HC
        Non-A non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin.
        Lancet. 1984; 2: 1062-1064
        • Williams PE
        • Yap PL
        • Gillon J
        • et al.
        Transmission of non-A, non-B hepatitis by pH4-treated intravenous immunoglobulin.
        Vox Sang. 1989; 57: 15-18
      1. Healey CJ, Watson J, Durridge M, et al. Treatment of acute hepatitic C with alpha interferon in agammaglobulinaemia. Gastroenterology. In press.

        • Healey CJ
        • Sabharwal NK
        • McOmish F
        • et al.
        Outbreak of acute hepatitis C following intravenous immunoglobulin therapy.
        Hepatology. 1994; 20 (Abstract): 249A